Press Release

iCAN:Israel-Cannabis Continues to Accelerate Cannabis Innovation, Signs MoU With New Israeli Medical Cannabis Company Yom Chai to Develop and Clinically Validate Suppository Based Cannabis Treatments

TEL AVIV, IsraelAug. 13, 2018 /PRNewswire/ — iCAN:Israel-Cannabis is pleased to announce that it has entered into a Memorandum of Understanding (“MoU”) with Yom Chai, Ltd to co-found the development and clinical validation of a range of cannabis based products.

Yom Chai has deep experience in the U.S. retail cannabis market opening and running dispensaries and production facilities as well as providing consulting services to a wide range of North American cannabis businesses.

Expanding its work in the industry with iCAN, Yom Chai, in collaboration with…